0.8418
price down icon0.95%   -0.0081
 
loading
Durect Corp stock is traded at $0.8418, with a volume of 47,392. It is down -0.95% in the last 24 hours and down -11.39% over the past month. Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
See More
Previous Close:
$0.8499
Open:
$0.86
24h Volume:
47,392
Relative Volume:
0.46
Market Cap:
$26.13M
Revenue:
$8.59M
Net Income/Loss:
$-17.07M
P/E Ratio:
-1.38
EPS:
-0.61
Net Cash Flow:
$-21.90M
1W Performance:
-0.96%
1M Performance:
-11.39%
6M Performance:
-47.06%
1Y Performance:
+14.98%
1-Day Range:
Value
$0.8203
$0.8645
1-Week Range:
Value
$0.7906
$0.8645
52-Week Range:
Value
$0.6802
$1.88

Durect Corp Stock (DRRX) Company Profile

Name
Name
Durect Corp
Name
Phone
(408) 777-1417
Name
Address
10240 BUBB ROAD, CUPERTINO, CA
Name
Employee
58
Name
Twitter
@DURECTCorp
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
DRRX's Discussions on Twitter

Compare DRRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
DRRX
Durect Corp
0.8418 26.13M 8.59M -17.07M -21.90M -0.61
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
167.53 75.58B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.24 41.78B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.10 41.53B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
21.82 24.72B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
145.88 14.77B 2.24B 385.90M 440.10M 3.73

Durect Corp Stock (DRRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-30-20 Initiated Chardan Capital Markets Buy
Oct-12-20 Initiated ROTH Capital Buy
Jul-31-20 Initiated Oppenheimer Outperform
Jan-31-20 Initiated B. Riley FBR Buy
Nov-18-19 Resumed Cantor Fitzgerald Overweight
Sep-06-19 Initiated Cantor Fitzgerald Overweight
Mar-06-18 Upgrade H.C. Wainwright Neutral → Buy
Oct-20-17 Downgrade H.C. Wainwright Buy → Neutral
Oct-20-17 Reiterated Laidlaw Buy
Oct-20-17 Downgrade Stifel Buy → Hold
Jul-12-17 Upgrade Stifel Hold → Buy
Feb-28-17 Resumed H.C. Wainwright Buy
Apr-25-16 Initiated Rodman & Renshaw Buy
May-01-15 Reiterated Cantor Fitzgerald Buy
May-01-15 Reiterated Stifel Buy
Mar-25-13 Initiated Stifel Buy
Nov-01-12 Downgrade C.K. Cooper Buy → Hold
Aug-17-12 Initiated C.K. Cooper Buy
Jun-23-09 Initiated Caris & Company Buy
Mar-26-09 Initiated Wedbush Morgan Hold
View All

Durect Corp Stock (DRRX) Latest News

pulisher
Jan 16, 2025

Durect (DRRX) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Jan 16, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Has $429,000 Holdings in DURECT Co. (NASDAQ:DRRX) - Defense World

Jan 13, 2025
pulisher
Jan 11, 2025

DURECT faces Nasdaq delisting over share price - Investing.com

Jan 11, 2025
pulisher
Dec 27, 2024

Reviewing Acerus Pharmaceuticals (OTCMKTS:TRLPF) and DURECT (NASDAQ:DRRX) - Defense World

Dec 27, 2024
pulisher
Dec 11, 2024

Durect (DRRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 11, 2024
pulisher
Dec 02, 2024

DURECT Corp expected to post a loss of 17 cents a shareEarnings Preview - XM

Dec 02, 2024
pulisher
Nov 28, 2024

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Nov 28, 2024
pulisher
Nov 26, 2024

DURECT Corp sells ALZET product line to Lafayette - TradingPedia

Nov 26, 2024
pulisher
Nov 25, 2024

Durect announces sale of Alzet line of osmotic pumps to LIC for $17.5M - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PR Newswire

Nov 25, 2024
pulisher
Nov 25, 2024

DURECT Sells ALZET Product Line for $17.5M, Extends Cash Runway to 2025 - StockTitan

Nov 25, 2024
pulisher
Nov 15, 2024

DURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 14, 2024

Earnings call: DURECT Corporation reports Q3 2024 financials - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... By GuruFocus - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Durect: Q3 Earnings Snapshot - Houston Chronicle

Nov 14, 2024
pulisher
Nov 13, 2024

Durect Corp Q3 2024 Earnings: GAAP EPS of -$0.14 Misses Estimates, Revenue at $1.9 Million Below Expectations - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Durect reports Q3 EPS (14c), consensus (17c) - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

DURECT Q3: $4.3M Loss, Plans Phase 3 Trial Amid Funding Needs & License Agreement End | DRRX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 06, 2024

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update - StockTitan

Nov 06, 2024
pulisher
Oct 18, 2024

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances - Citeline News & Insights

Oct 18, 2024
pulisher
Oct 17, 2024

DRRXDurect Corp Latest Stock News & Market Updates - StockTitan

Oct 17, 2024
pulisher
Oct 17, 2024

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 - StockTitan

Oct 17, 2024
pulisher
Oct 09, 2024

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com

Oct 09, 2024
pulisher
Oct 09, 2024

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ... - Yahoo Finance

Oct 09, 2024
pulisher
Sep 26, 2024

Durect Corp Annual Meeting Decisions and Shareholder Votes - TipRanks

Sep 26, 2024
pulisher
Sep 26, 2024

H.C. Wainwright maintains Neutral rating on Durect shares post FDA meeting - Investing.com

Sep 26, 2024
pulisher
Sep 25, 2024

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis - PR Newswire

Sep 25, 2024
pulisher
Sep 04, 2024

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference - PR Newswire

Sep 04, 2024
pulisher
Aug 23, 2024

Durect Corp (NQ: DRRX - Financial Content

Aug 23, 2024
pulisher
Aug 17, 2024

Durect (FRA:DC8A) Total Inventories : €2.30 Mil (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 16, 2024

DURECT Co. (NASDAQ:DRRX) Expected to Post Q3 2024 Earnings of ($0.14) Per Share - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

HC Wainwright Analysts Reduce Earnings Estimates for DURECT Co. (NASDAQ:DRRX) - Defense World

Aug 16, 2024
pulisher
Aug 15, 2024

DURECT Corporation (NASDAQ:DRRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 15, 2024
pulisher
Aug 14, 2024

Earnings call: DURECT Corp reports steady Q2 financials, plans Phase III trial - Investing.com India

Aug 14, 2024
pulisher
Aug 13, 2024

Durect: Q2 Earnings Snapshot - Houston Chronicle

Aug 13, 2024
pulisher
Aug 13, 2024

Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 13, 2024
pulisher
Aug 13, 2024

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update - PR Newswire

Aug 13, 2024
pulisher
Aug 08, 2024

DURECT (DRRX) Set to Announce Quarterly Earnings on Tuesday - Defense World

Aug 08, 2024
pulisher
Aug 08, 2024

DURECT Co. (NASDAQ:DRRX) Receives $27.50 Average Target Price from Brokerages - American Banking and Market News

Aug 08, 2024
pulisher
Aug 07, 2024

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update - StockTitan

Aug 07, 2024
pulisher
Aug 04, 2024

ProAssurance Co. (NYSE:PRA) Shares Bought by CANADA LIFE ASSURANCE Co - Defense World

Aug 04, 2024
pulisher
Aug 04, 2024

DURECT (DRRX) Stock Price, News & Analysis - MarketBeat

Aug 04, 2024
pulisher
Aug 04, 2024

Altair Engineering (NASDAQ:ALTR) Stock Rating Lowered by The Goldman Sachs Group - Defense World

Aug 04, 2024
pulisher
Jul 30, 2024

DURECT (NASDAQ:DRRX) Stock Price Passes Above Two Hundred Day Moving Average of $1.13 - MarketBeat

Jul 30, 2024
pulisher
Jun 29, 2024

Durect - The Pharma Letter

Jun 29, 2024
pulisher
May 21, 2024

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis - PR Newswire

May 21, 2024
pulisher
May 14, 2024

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript - Insider Monkey

May 14, 2024
pulisher
May 13, 2024

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update - PR Newswire

May 13, 2024

Durect Corp Stock (DRRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$30.10
price up icon 2.14%
$12.04
price up icon 0.17%
$94.05
price up icon 2.82%
$126.50
price up icon 0.24%
$11.33
price up icon 0.27%
$145.88
price up icon 1.83%
Cap:     |  Volume (24h):